Registries’ Role in Medicare Coverage of New Drugs for Alzheimer’s Disease
In a Viewpoint article, authors consider how a CMS registry could be used in evaluating “whether monoclonal antibodies are reasonable and necessary in the Medicare
In a Viewpoint article, authors consider how a CMS registry could be used in evaluating “whether monoclonal antibodies are reasonable and necessary in the Medicare
Administered with a selective serotonin reuptake inhibitor (SSRI) or a serotonin–norepinephrine reuptake inhibitor (SNRI), esketamine nasal spray produced greater remission at week 8 compared with
Out-of-hospital therapeutic errors involving medications for attention-deficit/hyperactivity disorder (ADHD) reported to U.S. poison control centers rose by nearly 300% between 2000 and 2021, researchers report.
In 35 general practices in England, brief nurse-delivered sleep restriction therapy was more effective than sleep hygiene interventions alone for insomnia, an open-label study shows.
In a pair of phase 3 trials, the investigational antidepressant zuranolone was effective in treating postpartum depression and major depressive disorder in adults. An editorialist
Second-generation antipsychotic agents and haloperidol have similar rates of in-hospital adverse clinical events in older patients with postoperative delirium, according to a study of people
In a phase 2 trial of adults aged 21 to 65 years with major depressive disorder (MDD), treatment with psilocybin “was associated with a clinically
In a retrospective cohort study of 72,496 older adults (65 years or older), benzodiazepines and anxiety disorders were associated with increased risk for dementia, but when
Compared with a control diet with mild caloric restriction, the Mediterranean–DASH Intervention for Neurodegenerative Delay (MIND) diet with mild caloric restriction resulted in similar changes
Use and misuse of alcohol are reviewed with a focus on pharmacotherapeutic management. “Alcohol is regularly consumed throughout most of the world, including by nearly